Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-26 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.240 | -0.070 | 0.1700 | ||||
| REV | 26.030M | 21.461M | -4.569M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RDHL | Redhill Biopharma | -1.12% | 330.4M |
Redhill Biopharma Company Questions & Answers
Q
How do I buy Redhill Biopharma (RDHL) stock?
A
You can purchase shares of Redhill Biopharma (NASDAQ: RDHL) through any online brokerage.
Q
Who are Redhill Biopharma's (RDHL) main competitors?
A
There are no as such competitors for Redhill Biopharma.
Q
What is the target price for Redhill Biopharma?
A
The latest price target for Redhill Biopharma (NASDAQ: RDHL) was reported by BTIG on 2020-09-11. The analyst firm set a price target for 26.00 expecting RDHL to rise to within 12 months (a possible 267.23% upside). 1 analyst firms have reported ratings in the last year.
Q
How much is Redhill Biopharma (RDHL) stock ?
A
The stock price for Redhill Biopharma (NASDAQ: RDHL) is $7.08 last updated Wed Apr 14 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
Q
When is the next Redhill Biopharma (RDHL) dividend?
A
There are no upcoming dividends for Redhill Biopharma.
Q
When is Redhill Biopharma (NASDAQ:RDHL) reporting earnings?
A
Redhill Biopharma’s Q1 earnings are confirmed after-market from now on May 26, 2021.
Q
When is the upcoming split for RDHL?
A
There is no upcoming split for Redhill Biopharma.